- On October 28, 2025, Xylem Inc. reported third-quarter earnings with revenue of US$2.27 billion and raised its full-year 2025 guidance, now expecting approximately US$9.0 billion in total revenue and improving projected growth rates.
- This move reflects significant momentum in Xylem’s measurement and control solutions and water services segments, supported by margin expansion and a continued focus on higher-value markets.
- We’ll now explore how Xylem’s improved full-year guidance impacts the company’s long-term investment narrative and future growth prospects.
These 16 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
Xylem Investment Narrative Recap
Being a shareholder in Xylem means believing in the ongoing modernization of water infrastructure, growing adoption of smart technologies, and Xylem’s ability to drive margin expansion by focusing on higher-value, recurring revenue segments. The recent upward revision in full-year revenue guidance supports the strength of these themes and underpins confidence in short-term growth catalysts, but it does not fundamentally lessen the risk of exposure to government funding cycles, which could still produce year-to-year revenue swings.
Of recent company announcements, Xylem’s partnership with Mexico City and Monterrey, aimed at implementing advanced water management solutions, is particularly relevant as it exemplifies the growing demand for digital infrastructure in water utilities. This relationship highlights momentum in Xylem’s Measurement and Control Solutions segment and directly supports its largest catalyst: expanding adoption of advanced metering and monitoring technology, which is driving the company’s improved revenue outlook.
However, in contrast to these tailwinds, investors should be aware of ongoing uncertainty around government infrastructure funding cycles that remain a risk to Xylem’s growth…
Read the full narrative on Xylem (it's free!)
Xylem's outlook anticipates $10.2 billion in revenue and $1.4 billion in earnings by 2028. This reflects a 5.2% annual revenue growth rate and a $462 million increase in earnings from the current $938.0 million.
Uncover how Xylem's forecasts yield a $158.67 fair value, a 5% upside to its current price.
Exploring Other Perspectives
Four recent fair value estimates from the Simply Wall St Community range from US$116.00 to US$158.67 per share. While investors’ opinions differ significantly, many are watching to see if rising demand for smart metering can offset potential volatility in public spending and support long-term performance.
Explore 4 other fair value estimates on Xylem - why the stock might be worth 23% less than the current price!
Build Your Own Xylem Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Xylem research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Xylem research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Xylem's overall financial health at a glance.
Looking For Alternative Opportunities?
Our top stock finds are flying under the radar-for now. Get in early:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.
- We've found 20 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Xylem might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com